Protein expression of the tumor suppressors p16INK4A and p53 and disease progression in recurrent respiratory papillomatosis

Laryngoscope

Volumn 117, Issue 2, 2007, Pages 253-257

  Pham, Truc T ^a   Ongkeko, Weg M ^b,c   An, Yi ^b   Yi, Eunhee S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Human papilloma virus (HPV); Invasive squamous carcinoma; P16INK4A; p53; Recurrent respiratory papillomatosis (RRP); Tumor progression; Tumor suppressors

Indexed keywords

PROTEIN P16INK4A; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BIOPSY; CANCER GRADING; CARCINOMA IN SITU; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT TRANSFORMATION; PAPILLOMATOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; RECURRENT RESPIRATORY PAPILLOMATOSIS; RESPIRATORY TRACT CANCER; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA;

ADOLESCENT; ADULT; BIOPSY; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; CELL TRANSFORMATION, NEOPLASTIC; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; RESPIRATORY TRACT NEOPLASMS; TRACHEAL NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33846847903     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000248241.95357.a6     Document Type: Article

References (16)

1. Armstrong LR, Preston EJ, Reichert M, et al. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis 2000;31:107-109.
2. Dedo HH, Yu KC. CO(2) laser treatment in 244 patients with respiratory papillomas. Laryngoscope 2001;111:1639-1644.
3. Penaloza-Plascencia M, Montoya-Fuentes H, Flores-Martinez SE, Fierro-Velasco FJ, Penaloza-Gonzalez JM, Sanchez-Corona J. Molecular identification of 7 human papillomavirus types in recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000;126:1119-1123.
4. Galloway DA, McDougall JK. The disruption of cell cycle checkpoints by papillomavirus oncoproteins contributes to anogenital neoplasia. Semin Cancer Biol 1996;7:309-315.
5. Kanao H, Enomoto T, Ueda Y, et al. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer. Cancer Lett 2004;213:31-37.
6. Wang JL, Zheng BY, Li XD, Angstrom T, Lindstrom MS, Wallin KL. Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res 2004;10:2407-2414.
7. Gologan O, Barnes EL, Hunt JL. Potential diagnostic use of p16INK4A, a new marker that correlates with dysplasia in oral squamoproliferative lesions. Am J Surg Pathol 2005;29:792-796.
8. Lele SM, Pou AM, Ventura K, Gatalica Z, Payne D. Molecular events in the progression of recurrent respiratory papillomatosis to carcinoma. Arch Pathol Lab Med 2002;126:1184-1188.
9. Xu H, Lu DW, El-Mofty SK, Wang HL. Metachronous squamous cell carcinomas evolving from independent oropharyngeal and pulmonary squamous papillomas: association with human papillomavirus 11 and lack of aberrant p53, Rb, and p16 protein expression. Hum Pathol 2004;35:1419-1422.
10. Rady PL, Schnadig VJ, Weiss RL, Hughes TK, Tyring SK. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53. Laryngoscope 1998;108:735-740.
11. Aaltonen L, Rihkanen H, Vaheri A. Human papillomavirus in larynx. Laryngoscope 2002;112:700-707.
12. Reidy P, Dedo H, Rabah R, et al. Integration of human papillomavirus type 11 in recurrent respiratory papilloma-associated cancer. Laryngoscope 2004;114:1906-1909.
13. Nunez D, Astley S, Lewis F, Wells M. Human papilloma viruses: a study of their prevalence in the normal larynx. J Laryngol Otol 1994;108:319-320.
14. Brandwein M, Nuovo G, Biller H. Analysis of prevalence of human papillomavirus in laryngeal carcinomas. Study of 40 cases using polymerase chain reaction and consensus primers. Ann Otol Rhinol Laryngol 1993;102:309-313.
15. Garcia-Milian R, Hernandez H, Panade L, et al. Detection and typing of human papillomavirus DNA in benign and malignant tumours of laryngeal epithelium. Acta Otolaryngol 1998;118:754-758.
16. Smith EM, Pignatari SS, Gray SD, Haugen TH, Turek LP. Human papillomavirus infection in papillomas and nondiseased respiratory sites of patients with recurrent respiratory papillomatosis using the polymerase chain reaction. Arch Otolaryngol Head Neck Surg 1993;119:554-557.